Back to Search
Start Over
Valneva completes recruitment for Phase 3 trial of chikungunya vaccine candidate in adolescents
- Source :
- M2 Pharma. February 14, 2023
- Publication Year :
- 2023
-
Abstract
- M2 PHARMA-February 14, 2023-Valneva completes recruitment for Phase 3 trial of chikungunya vaccine candidate in adolescents (C)2023 M2 COMMUNICATIONS Vaccine company Valneva SE (Nasdaq:VALN) (Euronext Paris:VLA) announced on Tuesday that [...]
- Subjects :
- Valneva SE -- Product development -- Recruiting
Euronext Paris S.A. -- Product development -- Recruiting
Biological products industry -- Product development
Vaccination
Biotechnology industry -- Product development
Clinical trials
Vaccines -- Product development
Securities industry -- Product development
Industry hiring
Securities industry
Chemistry
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- M2 Pharma
- Publication Type :
- News
- Accession number :
- edsgcl.737024657